Recent interest in the role of inflammation has sparked many studies to evaluate whether aspirin or other nonsteroidal anti-inflammatory drugs can prevent cancers.
In a case-control study designed to investigate the relation between pain relievers and prostate cancer risk, investigators evaluated the relationship between the use of anti-inflammatory drugs and the risk of prostate caner in 2000 individuals between 2002 and 2005.
The investigator found that use of aspirin was association with a significant 21% reduction in the risk of prostate cancer when compared with aspirin nonusers.
Furthermore, long-term use of aspirin and daily use of low-dose aspirin were associated with a 24% and 29% reduction in prostate cancer risk respectively.
Use of non-aspirin NSAIDs or acetaminophen, however, did not have any impact on prostate cancer risk.
As mentioned in previous articles, use of aspirin is associated with GI bleedings. Readers are advised to consult their physicians before taking aspirin on a regular basis.
Source: Eur J Heart Fail. 2010 ;12(7) :706-715
Please visit healthreason.com for more health related articles.
